CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris Pharmaceuticals, the leading sirtuin therapeutics company, announced today that it will be presenting at the BIO Investor Forum in San Francisco. Sirtris will discuss the Company’s strategy for discovering and developing first in class therapeutics that modulate sirtuins, a recently discovered family of enzymes that promote healthy cellular function. The presentation will be delivered at 10:40 PST on Thursday, October 19th, 2006.
